Inhibition of Bcl-2 leads to autophagic cell death in MCF7 breast cancer cells.24 Therefore these evidences suggest that modulating autophagy may be important in designing anticancer therapies.22 Finally, studies suggest that the genetic makeup of cells will determine its fate in terms of undergoing autophagy and response to standard or novel therapies. This evidence concerns the gene BCL2 and breast cancer.